Theravance Biopharma, Inc. (TBPH)
20.21
+0.20
(+1.00%)
USD |
NASDAQ |
Jan 20, 13:55
Theravance Biopharma Market Cap: 1.024B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.665B |
| Perspective Therapeutics, Inc. | 179.15M |
| Skye Bioscience, Inc. | 32.38M |
| Kyntra Bio, Inc. | 36.86M |
| Myomo, Inc. | 36.46M |
Market Cap Related Metrics
| PE Ratio | 35.93 |
| PS Ratio | 12.68 |
| Price to Book Value | 4.401 |
| Price to Free Cash Flow | 4.184 |
| Price | 20.21 |
| Earnings Yield | 2.78% |
| Normalized PE Ratio | 35.93 |